Kurt T. Peterson
First Light Asset Management, Llc
Assets Managed
$1.116B
Holdings
35
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
-14.68%(2Q avg: 4.31%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in First Light Asset Management, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 35 positions.
Assets under management
The assets under management (AUM) of First Light Asset Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.116B in assets, with a quarterly growth rate of -14.68% and a 2-quarter average growth rate of 4.31%. The portfolio is managed by Kurt T. Peterson, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
AXGN Axogen Inc
| 11.89% | $132.612M 4.003M shares@ $33.14 avg price | Decreased -23.51% |
PVLA Palvella Therapeutics Inc
| 10.96% | $122.251M 980,758 shares@ $124.66 avg price | Increased 38.31% |
NEO Neogenomics Inc
| 6.47% | $72.196M 9.73M shares@ $7.43 avg price | Decreased -3.04% |
SIBN Si-bone Inc
| 6.06% | $67.611M 5.353M shares@ $12.64 avg price | Increased 6.37% |
CNTA Centessa Pharmaceuticals-adr
| 5.56% | $62.003M 1.561M shares@ $39.73 avg price | Decreased -31.5% |
APGE Apogee Therapeutics Inc
| 4.35% | $48.539M 576,684 shares@ $84.17 avg price | Increased 102.36% |
AMLX Amylyx Pharmaceuticals Inc
| 3.98% | $44.35M 3.191M shares@ $13.91 avg price | Decreased -4.91% |
TWST Twist Bioscience Corp
| 3.75% | $41.763M 878,848 shares@ $47.53 avg price | Decreased -22.96% |
CRNX Crinetics Pharmaceuticals In
| 3.55% | $39.577M 1.09M shares@ $36.32 avg price | Decreased -8.75% |
MASS 908 Devices Inc
| 3.34% | $37.164M 6.073M shares@ $6.13 avg price | Increased 25.57% |
1-10 of 35